General form of registration statement for all companies including face-amount certificate companies

Summary of Significant Accounting Policies (Tables)

v3.24.0.1
Summary of Significant Accounting Policies (Tables)
 9 Months Ended 12 Months Ended
Sep. 30, 2023
Dec. 31, 2022
Summary of Significant Accounting Policies [Abstract]    
Schedule of Net Income (Loss) Per Share Basic and Diluted Weighted Average Shares Outstanding The following table details the net loss per share calculation, reconciles between basic and diluted weighted average shares outstanding, and presents the potentially dilutive shares that are excluded from the calculation of the weighted average diluted common shares outstanding, because their inclusion would have been anti-dilutive:
    For the Three Months Ended
September 30,		     For the Nine Months Ended
September 30,		  
    2023     2022     2023     2022  
Numerator:                        
Net loss   $ (10,265,760 )   $ (21,486,978 )   $ (18,708,007 )   $ (16,983,981 )
                                 
Weighted average shares outstanding (denominator for basic earnings per share)     7,951,954       1,959,087       5,658,831       1,790,176  
                                 
Weighted average shares and assumed potential common shares (denominator for diluted earnings per share, treasury method)     7,951,954       1,959,087       5,658,831       1,790,176  
                                 
Basic loss per share   $ (1.29 )   $ (10.97 )   $ (3.31 )   $ (9.49 )
Diluted loss per share   $ (1.29 )   $ (10.97 )   $ (3.31 )   $ (9.49 )

 

  
Schedule of Anti Dilutive Common Shares The following common share equivalents are excluded from the calculation of weighted average common shares outstanding, because their inclusion would have been dilutive:
    For the Three Months Ended
September 30,		     For the Nine Months Ended
September 30,		  
    2023     2022     2023     2022  
Options    
-
       162,957      
-
       162,957  
Warrants     3,284,483       864,300       3,284,483       864,300  
Total potentially dilutive shares     3,284,483       1,027,257       3,284,483       1,027,257  
The following common share equivalents are excluded from the calculation of weighted average common shares outstanding, because their inclusion would have been anti-dilutive:
    For the Years Ended
December 31,		  
    2022     2021  
Options     162,956       137,050  
Warrants     3,435,728       557,695  
Total potentially dilutive shares     3,598,684       694,745